MRP: ₹19780
₹16145
₹ 3635 Off
(Incl. of all taxes)
Qty
Buying in bulk?
In stock Only 2 left
Deliver to
- 7-day returns
- Secure payment
- International shipping
- Carefully packed
Get this at ₹ 15338Extra 5% OffAdd items worth ₹999 to the cart & get extra 5% off
Get this at ₹ 14531Extra 10% OffAdd items worth ₹1499 to the cart & get extra 10% off
Book Summary
About the Book: Molecular Determinants of Head and Neck Cancer: 2nd Edition
Squamous cell cancers of the head and neck (SCCHN), also known as head and neck
cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and
pharynx, and are diagnosed in over 500,000 patients worldwide each year,
accounting for 5% of all malignancies. It is estimated that approximately 50,000
patients develop head and neck cancer annually in the United States, of whom
approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is
multimodal, often combining surgery or irradiation with chemotherapy; even
successfully treated patients frequently experience durable and severe side
effects. Improving
- ISBN-13
- 9783319787619
- Language
- English
- Binding
- Hard Bound
- Publisher
- Birkhauser Verlag AG
- Publishing Date
- 2018-08-19
- Total Pages
- 629
Molecular Determinants of Head and Neck Cancer: 2nd Edition
by Barbara Burtness, Erica A. Golemis (Author),
Birkhauser Verlag AG (Publisher)
fictionfantasyyoung adultaward winning
Frequently bought together
Molecular Determinants of Head and Neck Cancer: 2nd Edition₹16145This item
Maarikaadu₹63
Natyamayuri₹63Total for 3 items₹16271₹19920You save ₹3649
Product Specifications
Book Summary
About the Book: Molecular Determinants of Head and Neck Cancer: 2nd Edition
Squamous cell cancers of the head and neck (SCCHN), also known as head and neck
cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and
pharynx, and are diagnosed in over 500,000 patients worldwide each year,
accounting for 5% of all malignancies. It is estimated that approximately 50,000
patients develop head and neck cancer annually in the United States, of whom
approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is
multimodal, often combining surgery or irradiation with chemotherapy; even
successfully treated patients frequently experience durable and severe side
effects. Improving
Book Specifications
- ISBN-13
- 9783319787619
- Language
- English
- Binding
- Hard Bound
- Publisher
- Birkhauser Verlag AG
- Publishing Date
- 2018-08-19
- Total Pages
- 629